ARK Investment Management LLC - 31 Mar 2025 SCHEDULE 13G/A Report for CRISPR Therapeutics AG Common Stock (CRSP)

Filing Manager
ARK Investment Management LLC
Reporting Manager
ARK Investment Management LLC
Security
CRISPR Therapeutics AG Common Stock
Symbol
CRSP
Shares outstanding
85,783,966 shares
Disclosed Ownership
10,165,400 shares
Ownership
11.9%
Form type
SCHEDULE 13G/A
Filing time
14 May 2025, 10:52:57 UTC
Date of event
31 Mar 2025
Previous filing
14 Feb 2025
Next filing
04 Nov 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ARK Investment Management LLC 11.85% 10,165,400 9,547,322 221,181 /s/ Kellen Carter Kellen Carter, Chief Compliance Officer
Catherine D. Wood 11.85% 10,165,400 0 9,768,503 /s/ Catherine D. Wood Catherine D. Wood, Chief Executive Officer, Chief Investment Officer